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Abstract
Inhibitory glycinergic neurotransmission is terminated by sodium and chloride-dependent plasma membrane glycine
transporters (GlyTs). The mainly glial glycine transporter GlyT1 is primarily responsible for the completion of inhibitory
neurotransmission and the neuronal glycine transporter GlyT2 mediates the reuptake of the neurotransmitter that is used to
refill synaptic vesicles in the terminal, a fundamental role in the physiology and pathology of glycinergic neurotransmission.
Indeed, inhibitory glycinergic neurotransmission is modulated by the exocytosis and endocytosis of GlyT2. We previously
reported that constitutive and Protein Kinase C (PKC)-regulated endocytosis of GlyT2 is mediated by clathrin and that PKC
accelerates GlyT2 endocytosis by increasing its ubiquitination. However, the role of ubiquitination in the constitutive
endocytosis and turnover of this protein remains unexplored. Here, we show that ubiquitination of a C-terminus four lysine
cluster of GlyT2 is required for constitutive endocytosis, sorting into the slow recycling pathway and turnover of the
transporter. Ubiquitination negatively modulates the turnover of GlyT2, such that increased ubiquitination driven by PKC
activation accelerates transporter degradation rate shortening its half-life while decreased ubiquitination increases
transporter stability. Finally, ubiquitination of GlyT2 in neurons is highly responsive to the free pool of ubiquitin, suggesting
that the deubiquitinating enzyme (DUB) ubiquitin C-terminal hydrolase-L1 (UCHL1), as the major regulator of neuronal
ubiquitin homeostasis, indirectly modulates the turnover of GlyT2. Our results contribute to the elucidation of the
mechanisms underlying the dynamic trafficking of this important neuronal protein which has pathological relevance since
mutations in the GlyT2 gene (SLC6A5) are the second most common cause of human hyperekplexia.
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Introduction
Inhibitory glycine neurotransmission is terminated by specific
transporters, GlyTs (GlyT1 and GlyT2), which mediate the
reuptake of glycine from the synaptic cleft. GlyTs belong to the
neurotransmitter:sodium symporter family (SLC6 gene family),
which includes transporters for most of the neurotransmitters
(serotonin, dopamine, norepinephrine and GABA) in the central
nervous system (CNS) [1]. By mediating the synaptic recycling of
glycine, the neuronal transporter GlyT2 preserves the quantal
glycine content in synaptic vesicles and assists GlyT1 in regulating
glycine levels at the synaptic cleft. Gene deletion studies suggest
that modification of glycine transporter activity may be beneficial
in several human disorders, including neuromotor deficiencies
(startle disease, myoclonus), pain and epilepsy [2–4]. Indeed,
missense, nonsense, frameshift, and splice site mutations in the
gene encoding GlyT2 can induce hyperekplexia in humans and
congenital muscular dystonia type 2 (CMD2) in Belgian Blue cattle
[5–9]. In addition, a microdeletion in SLC6A5 as cause of startle
disease in Irish Wolfhounds has been reported [10].
Protein trafficking plays a fundamental role in the control of
neuronal activity and it has been identified as a primary regulatory
mechanism for several plasma membrane neurotransmitter
transporters, providing a rapid means to modulate their activity
[11]. The surface expression of GlyT2 is controlled by a variety of
stimuli that influence its trafficking, including PKC and syntaxin
1A [12,13]. GlyT2 is recycled between the cell surface and the cell
interior along constitutive and PKC-regulated trafficking pathways
[14], and a large proportion of GlyT2 resides in intracellular
endosomal membranes of rat brainstem neurons and heterologous
cells under steady-state conditions [15,16].
Recent findings have demonstrated the importance of ubiqui-
tination in the endocytosis of several membrane proteins,
suggesting that the attached ubiquitin molecule may act as a
platform for the recruitment of the clathrin-dependent endocytic
machinery [17,18]. In fact, ubiquitination is the mechanism
proposed to mediate PKC-dependent endocytosis of neurotrans-
mitter transporters [19–22]. Accordingly, we recently demonstrat-
ed that clathrin-mediated endocytosis is the main mechanism
driving constitutive and regulated GlyT2 internalization and the
lysine 791 in the C-terminal tail of GlyT2 was proposed to be the
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major determinant of PKC-induced internalization [23]. Howev-
er, the role of ubiquitination in the constitutive endocytosis of
membrane neurotransporters is less clear. Indeed, the dopamine
transporter DAT is constitutively internalized in an ubiquitination-
independent manner [24], while the constitutive endocytosis of
GlyT1 and the glutamate transporter GLT1 requires the
ubiquitination of several lysines. Hence, it appears that the
requirement of ubiquitination is not a general condition for
constitutive endocytosis of these transporters [19,25].
In the present study, we investigated the possible role of
ubiquitination in the constitutive internalization of neuronal
GlyT2 and its sorting to recycling and/or degradation pathways.
Our results show that constitutive endocytosis of GlyT2 is
dependent on the ubiquitination of the cytoplasmic C-terminal
lysine cluster (K751, K773, K787 and K791). The dynamic
ubiquitination/deubiquitination process controls GlyT2 turnover
through constitutive sorting mainly to the recycling pathway and
targeting the transporter primarily to the degradation pathway via
PKC-mediated ubiquitination. In neurons, the ubiquitination
status of GlyT2 is highly responsive to the free ubiquitin pool,
which is mainly controlled by UCHL1 deubiquitinase [26,27].
Thus, UCHL1 activity may indirectly modulate the turnover of
neuronal GlyT2. These findings demonstrate the requirement of
ubiquitination in the regulation of neuronal GlyT2, a key protein
in the physiology and pathology of glycinergic neurotransmission.
Materials and Methods
Materials
Male wistar rats were bred under standard conditions at the
Centro de Biologı´a Molecular Severo Ochoa. All animal work
performed in this study was carried out in accordance with
procedures approved in the Directive 86/609/EEC of the
European Union with approval of the Ethics Committee of the
Universidad Auto´noma de Madrid. PYR-41 (4-[4-(5-nitro-furan-
2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl]-benzoic acid ethyl es-
ter), and inhibitors of UCH-L1 [LDN-57444 (LDN)] and ubiquitin
C-terminal hydrolase-L3 (UCH-L3) (4, 5, 6, 7-tetrachloroindan-
1,3-dione, TCID) were purchased from Calbiochem (San Diego,
CA). All other chemicals were purchased from Sigma-Aldrich.
Antibodies against GlyT2 (rabbit and rat: [28,16]), calnexin
(Stressgen), syntenin-1 (Abcam), tubulin (Sigma-Aldrich) and
syntaxin1A and Ubiquitin (Clone P4D1) (Santa Cruz) were used.
Agarose-conjugated anti-multiubiquitin (monoclonal antibody,
Figure 1. Pharmacological inhibition of the E1 ubiquitin-activating enzyme activity reduces constitutive GlyT2 endocytosis. A–D)
MDCK cells were transfected to express wild-type GlyT2, and were preincubated for 2 h with vehicle (A, B) or PYR-41 (50 mM) (C, D). Then were
incubated for 30 min with vehicle (A, C) or monensin (35 mM) (B, D) maintaining the previous pretreatment. The cells were then fixed with 4%
paraformaldehyde, immunostained to visualize GlyT2 and analyzed by confocal microscopy. Scale bar = 15 mm. Note the reduction in constitutively
endocytosed GlyT2 in the presence of monensin and PYR-41 (D). E) Quantification of GlyT2 fluorescence intensity at the cell surface was performed as
described in Materials and Methods. The histogram represents the mean 6 SEM (n = 4; on average, 30 cells per condition were analyzed in each
experiment). **, significantly different, p,0.01 by ANOVA with Tukey’s post hoc test. n.s., not statistically significant. F) MDCK cells expressing wild-
type GlyT2 were incubated with PYR-41 or the vehicle alone, as described above, the cells were lysed and the ubiquitinated transporters were
immunoprecipitated with agarose-conjugated anti-multiubiquitin antibody. The immunoprecipitates were probed with an anti-GlyT2 antibody. Ub,
anti-multiubiquitin immunoprecipitation (75 mg); T, total protein (10 mg). G) Quantification of three experiments performed as described in (F). Bars
represent the mean6 SEM levels of PYR-41-treated ubiquitinated transporter relative to those of ubiquitinated transporter in control cells exposed to
the vehicle alone. *, significant difference relative to controls; p,0.05 (Student’s t-test).
doi:10.1371/journal.pone.0058863.g001
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Figure 2. Mutation of each lysine of the GlyT2 C-terminal does not impair GlyT2 constitutive endocytosis. A) Multiple sequence
alignment of rat GlyT2 C-terminus region (740–799) from different species was obtained with the CLUSTAL 2.1 multiple sequence alignment method.
Identical conserved lysines from different species are shown in red. B-C) MDCK cells expressing wild-type GlyT2 or one of four different point mutants
(K751R, K773R, K787R or K791R) were exposed for 30 min to monensin (35 mM) at 37uC or the vehicle alone, fixed with 4% paraformaldehyde,
immunostained to visualize GlyT2 and analyzed by confocal microscopy. To simplify the figure, only the wild-type GlyT2 control (Veh) is displayed (all
other controls were comparable). Scale bar = 15 mm. C) Representative immunoblot of MDCK cells expressing wild-type GlyT2 or the indicated
mutants. Cells were treated with monensin or the vehicle alone, as described above. The cell surface proteins were labeled with sulfo-NHS-SS-biotin
Ubiquitination in GlyT2 Endocytosis and Turnover
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and biotinylated proteins were pulled down with streptavidin-agarose beads. GlyT2 expression was analyzed in Western blots and calnexin
immunodetection was used as a non-biotinylated protein control. B, biotinylated protein (30 mg); T, total protein (10 mg). D) Densitometric analysis of
three independent Western blots as shown in (C), relative to the control values (Veh). E) [3H]-Glycine uptake during 10 minutes was measured in
MDCK cells expressing wild-type GlyT2 or the mutants indicated and transport activity is denoted in nmol of glycine/mg of protein. The data
represent the means 6 SEM and no significant differences respect to vehicle were observed performing ANOVA analysis (with Tukey’s post-hoc test).
doi:10.1371/journal.pone.0058863.g002
Figure 3. The 4KR GlyT2 mutant exhibits impaired endocytosis and lower basal ubiquitination than wild-type GlyT2. A–D) MDCK cells
were transfected with wild-type GlyT2 or with 4KR mutant cDNAs (GlyT2 with lysines in positions 751, 773, 787 and 791 mutated to arginines). After
48 h the cells were exposed for 30 min to monensin (35 mM) at 37uC or the vehicle alone, fixed with 4% paraformaldehyde, immunostained to
visualize GlyT2 and analyzed by confocal microscopy. Scale bar = 15 mm. Note that endocytosis of the 4KR mutant is blocked in the presence of
monensin (D). E) Representative immunoblot of MDCK cells expressing wild-type GlyT2 or the 4KR mutant. Cells were treated for 30 min with the
vehicle alone or with monensin (35 mM) at 37uC. Cell surface proteins were labeled with sulfo-NHS-SS-biotin and the biotinylated proteins were
pulled down with streptavidin-agarose beads. GlyT2 expression was analyzed in Western blots and calnexin immunodetection was used as a non-
biotinylated protein control. B, biotinylated protein (30 mg); T, total protein (10 mg). F) Densitometric analysis of four independent Western blots as in
(E) relative to the control values (veh). Data represent means 6 SEM. **, significant difference with respect to control, p,0.01 (ANOVA with Tukey’s
post-hoc test). Note that constitutive endocytosis of the 4KR mutant is blocked in the presence of monensin. G) MDCK cells expressing wild-type
GlyT2 or the 4KR mutant were lysed, ubiquitinated proteins were immunoprecipitated with agarose-conjugated anti-multiubiquitin antibodies, and
GlyT2 was analyzed in Western blots. Ub, anti-multiubiquitin immunoprecipitation (50 mg); T, total protein (10 mg). H) Quantification of four
experiments performed as described in (G). Bars represent the mean 6 SEM of the amount of 4KR mutant ubiquitinated transporter relative to the
amount of wild-type ubiquitinated transporter. *, significant difference with respect to control, p,0.05 (Student’s t-test). I) [3H]-Glycine uptake during
10 minutes was measured in MDCK cells expressing wild-type GlyT2 or the 4KR mutant and transport activity is denoted in nmol of glycine/mg of
protein. The data represent the means 6 SEM and no significant differences respect to vehicle were observed performing student’s t-test.
doi:10.1371/journal.pone.0058863.g003
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clone FK2) was purchased from MBL International. Fluorophore-
coupled secondary antibodies were acquired from Molecular
Probes. Multiple sequence alignment was performed with
CLUSTAL 2.1 multiple sequence alignment software, using the
rat GlyT2 sequence as the query at www.ebi.ac.uk.
Primary cultures of neurons
The brainstem and spinal cord from 16-day-old Wistar rat
fetuses or the hippocampus from 18-day-old Wistar rat fetuses
were isolated in Hank’s Balanced Salt Solution buffer (Invitrogen),
dissociated with trypsin as described previously [29] and grown in
culture plates. After 2 days, cytosine arabinoside (2.5 mM) was
added to inhibit further glial growth and the primary neurons were
studied after 14 days in culture.
Transfection of MDCK cells and hippocampal neurons
Madin – Darby canine kidney II (MDCK II) cells (American
Type Culture Collection) were grown at 37uC and 5% CO2 in
minimal essential medium supplemented with 10% fetal bovine
serum. Transient expression was achieved using LipofectamineTM
2000 (Invitrogen) following the manufacturer’s instructions.
Reproducible results were obtained with 50–60% confluent cells
in a 60 mm dish using 6 mg of total DNA. The cells were
incubated for 48 h at 37uC before the experiment was performed.
Hippocampal neurons were obtained as described above. The cells
(DIV10) were transfected with Effectene (Qiagen) following
manufacturer’s instructions using 10 ml of Effectene per 1 mg of
DNA in a 12 mm dish.
Generation of mutants
Substitution mutants were generated with the QuikChange Site-
Directed Mutagenesis kit (Stratagene), using the rat GlyT2 in
pCDNA3 as described previously [29]. The 4KR mutant (GlyT2
mutant in which all the C-terminal lysines are substituted by
arginines) was created via four consecutive rounds of Polymerase
Chain Reaction (PCR) site-directed mutagenesis, one for each C-
terminal lysine-to-arginine mutation. All point mutations were
verified by sequencing.
Immunocytochemistry and confocal imaging
MDCK II cells and hippocampal neurons were grown on glass
coverslips and transfected with the corresponding expression
vectors as indicated above. Immunostaining was performed as
described previously [23] and the cells were visualized by confocal
microscopy on a Microradiance microscope (BioRad) using a
vertical Axioskop 2 microscope (Zeiss), or with a LSM510 META
confocal microscope coupled to an inverted AXIOVERT 200
microscope (Zeiss). IMAGEJ (National Institutes of Health)
software and LSM image browsers (Carl Zeiss Inc.) were used
for image processing.
Anti-multiubiquitin immunoprecipitation
Brainstem and spinal cord primary neurons (100 mg) or MDCK
II cells were lysed for 30 min at room temperature (RT) at a
concentration of 1 mg of protein/ml in TN buffer (25 mM
TrisHCl and 150 mM NaCl, pH 7.4) containing 0.25% Nonidet
P-40 (NP-40), 50 mM N-ethylmaleimide and protease inhibitors
(PIs: 0.4 mM phenylmethylsulfonyl fluoride [PMSF] + Sigma
cocktail). Agarose-conjugated anti-multiubiquitin (12 ml) was
added and incubated for 1 h at RT. The beads were collected
by mild centrifugation and washed 3 times for 5 minutes with lysis
buffer. Finally, the beads were pelleted and the ubiquitinated
proteins were eluted in Laemmli buffer at 75uC for 10 min,
resolved in sodium dodecyl Sulfate Polyacrylamide Gel electro-
phoresis (SDS/PAGE) gels (7.5%), detected in Western blots with
enhanced chemiluminescence (ECL) and quantified on a GS-710
calibrated imaging densitometer (Bio-Rad).
Cell surface labelling with Sulfo-NHS-SS-biotin
Surface proteins of transfected MDCK II cells or primary
brainstem and spinal cord neurons (14 DIV) were washed with
1.0 ml of Phosphate Buffered Saline (PBS) at 4uC and incubated
for 40 min at 4uC with 1 mg/ml of non-permeable sulfo-NHS-SS-
biotin reagent (Thermo Fisher Scientific) in PBS. Cells were then
washed 3 times with 1 ml of the same solution supplemented with
100 mM lysine and scraped in 50 mM Tris-HCl [pH 7.4],
150 mM NaCl (TN) buffer plus 0.4 mM phenylmethylsulfonyl-
fluoride (PMSF) and protease inhibitor mixture (Sigma). Total
Figure 4. Mutation of the C-terminal lysine cluster of GlyT2
does not impair its neuronal localization in transfected
hippocampal neurons. A–C) Hippocampal neurons were transfected
with wild type GlyT2 or with the 4KR mutant at 10 DIV. Three days after
transfection, the cultures were fixed in pre-cooled 100% methanol at
220uC and stained for GlyT2 (green), syntaxin1A (red) and syntenin-1
(blue) specific antibodies. General scale bar, 40 mm. Scale bar in detailed
images, 5 mm. C) Quantification of co-localization between syntaxin1A
and GlyT2, or between syntenin-1 and GlyT2, was performed using
Pearson’s value of correlation as described in Materials and Methods.
Note there is no significant difference in the neuronal localization
between GlyT2 and 4KR mutant, by Student’s T-test. The histogram
represents the mean6 SEM (n= 3; on average, 30 images per condition
were analyzed in each experiment).
doi:10.1371/journal.pone.0058863.g004
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Figure 5. Endocytosed GlyT2 co-localizes with GFP-Rab11, whereas the 4KR mutant fails to internalize and accumulates in the
surface. A-H) MDCK cells were transfected with wild-type GlyT2 and GFP-Rab7 (A, B) or GFP-Rab11 (C, D), or with the 4KR mutant and GFP-Rab7 (E, F)
or GFP-Rab11 (G, H). After 48 h the cells were incubated for 30 min with monensin (35 mM) or the vehicle alone and fixed with 4% paraformaldehyde.
GFP-Rab7 and GFP-Rab11 were visualized by GFP fluorescence (green), whereas GlyT2 was detected with the anti-GlyT2 antibody (shown in red).
Note the increase in intracellular vesicles in monensin-treated cells expressing wild-type GlyT2 (B, D), which colocalizes with GFP-Rab11 (D) but not
Ubiquitination in GlyT2 Endocytosis and Turnover
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GFP-Rab7 (B). This increase was not observed in cells expressing the 4KR mutant transporter (F, H). Scale bar = 15 mm. I) Quantification of
colocalization using Pearsons value was performed as described in Materials and Methods. Note the increase of colocalization between Rab11 and
wild type GlyT2 in the presence of monensin, which cannot be observed with 4KR mutant. The histogram represents the mean 6 SEM (n= 3; on
average, 30 images per condition were analyzed in each experiment).**, significantly different, p,0.01 by ANOVA with Tukey’s post hoc test.
doi:10.1371/journal.pone.0058863.g005
Figure 6. Reduction of GlyT2 C-terminal ubiquitination increases its constitutive stability and attenuates PMA-induced
degradation. A) Representative immunoblot of MDCK cells expressing wild-type GlyT2 or the 4KR mutant. Cells were treated with cycloheximide
(CHX: 10 mg/ml) or CHX plus PMA (1 mM) for the times indicated. The cells were then harvested, lysed and whole cell lysates (20 mg/lane) were
resolved by SDS-PAGE and analyzed by immunoblotting with the anti-GlyT2 antibody. As a loading control, blots were reprobed with anti-tubulin. B)
Degradation curves were generated by measuring GlyT2 band densities and normalizing them to corresponding tubulin band densities, designating
time zero as 100%. Black curves correspond to CHX + DMSO conditions and grey curves correspond to CHX + PMA conditions. Densitometric analysis
of three independent Western blots as in (A) was performed with the data representing the means 6 SEM. C–F) MDCK cells were transfected with
wild-type GlyT2 and GFP-Rab11 (C, D) or GFP-Rab7 (E, F). After 48 h the cells were incubated for 2 hours with PMA (1 mM) or the vehicle and fixed
with 4% paraformaldehyde. GFP-Rab7 and GFP-Rab11 were visualized by GFP fluorescence (green), whereas GlyT2 was detected with the anti-GlyT2
antibody (shown in red). Note the increase in intracellular vesicles in PMA-treated cells expressing wild-type GlyT2 (D, F) which colocalizes with GFP-
Rab7 (F). Scale bar = 15 mm. G) Quantification of colocalization using Pearsons value was performed as described in Materials and Methods. The
histogram represents the mean 6 SEM (n= 3; on average, 30 images per condition were analyzed in each experiment). **, significantly different,
p,0.01 by ANOVA with Tukey’s post hoc test.
doi:10.1371/journal.pone.0058863.g006
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proteins were solubilized for 30 min at 4uC in RIPA buffer
(150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1% SDS and
0.25% sodium deoxycholate). Streptavidin-agarose beads (40 ml
per sample: Sigma) were added and incubated for 1 h at 4uC with
agitation. Bead-bound biotinylated proteins (B) were eluted for
15 min at 70uC with Laemmli buffer (40 mM Tris [pH 6.8], 2%
SDS, 10% glycerol, 0.1 mM dithiothreitol and 0.01% bromophe-
nol blue). Total protein (T; 10 mg) and biotinylated protein (B;
30 mg) were run on a 7.5% SDS-polyacrylamide gel and after
analyzed by Western blot with specific GlyT2 antibodies, the
bands were visualized by ECL and quantified in the linear range
on a GS-710 calibrated imaging densitometer (Bio-Rad) with
Quantity One software. Calnexin immunoreactivity was used as a
non-biotinylated protein control. The standard error of the mean
(S.E.M) was calculated after densitometric analysis of at least three
separate experiments.
Glycine transport assay
Transport assays in MDCK cells were performed at 37uC in
PBS plus 10 mM glucose, containing 2 mCi/ml [3H]-labelled
glycine (1.6 TBq/mmol; PerkinElmer) diluted to a final glycine
concentration of 10 mM, as described previously [23]. Reactions
were terminated after 10 min by aspiration and transport was
quantified by subtracting the glycine accumulated in mock-
transfected MDCK cells from that of the transporter-transfected
cells and normalized to the protein concentration.
Quantification of co-localization and cell surface rates
from immunofluorescence microscopy images
To perform the quantification of co-localization, Pearsons value
was analyzed with IMAGEJ software (National Institutes of
Health), using at least 30 images for each condition. Images were
processed with a 2.0 pixel median filter, and threshold used was
automatically determined by JACoP plugin [30]. Pearsons value
was obtained with JACoP by comparing the two thresholded
channels and measuring the correlation between them. The value
can range from -1 to 1, being 1 the maximal co-localization
possible (two identical images), and usually values from 0.5 to 1.0
can be considered as a valid co-localization [31]. The quantifica-
tion of cell surface GlyT2 was performed as described previously
[23].
Data Analysis
All statistical analyses were performed using SPSS 19.0 (SPSS
Inc., Chicago, IL) and graphs and curves were generated with
Origin 8.0 (OriginLab Corp, MA). One-way analysis of variance
(ANOVA) was used to compare multiple groups, with subsequent
Tukey’s post-hoc test to determine the significant differences
between samples. The Student’s t-test was used to compare two
separate groups. p values ,0.05 were considered significant.
Results
The constitutive endocytosis of GlyT2 is regulated by
ubiquitination of its C-terminal lysines
Ubiquitination is a well-described post-translational modifica-
tion involved in the PKC-induced endocytosis of various
membrane proteins, including dopamine, glutamate and glycine
transporters (DAT, GLT1, GlyT1b, GlyT2). However, its role in
the constitutive endocytosis of these proteins is less understood. We
recently demonstrated a direct relationship between the ubiqui-
tination of lysine 791 in the C-terminus of the neuronal glycine
transporter GlyT2 and its PKC-dependent endocytosis. Hence, in
the present study we investigated whether the constitutive
endocytosis of GlyT2 was also ubiquitin-dependent, initially using
the MDCK cell line, a suitable background for our immunoflu-
orescence studies due to the efficient and uniform expression of
transfected GlyT2 at the cell surface of these cells, as described
previously [23]. To study the constitutive endocytosis of GlyT2 we
used the cationophore monensin, an experimental strategy
commonly employed to analyze the constitutive endocytosis of
membrane proteins. Monensin is an inhibitor of transport via
acidic endosomal compartments and thus, interferes with the
Figure 7. Basal ubiquitination of GlyT2 in neurons decreases
when the pool of free monomeric ubiquitin is reduced. A)
Brainstem and spinal cord primary neurons were treated with DMSO,
UCHL1 inhibitor (10 mM) or UCHL3 inhibitor (10 mM) for the times
indicated at 37uC. After lysis, the ubiquitinated proteins were
immunoprecipitated with agarose-conjugated anti-multiubiquitin anti-
bodies and the endogenous GlyT2 was analyzed in Western blots. Ub,
anti-multiubiquitin immunoprecipitation (50 mg); T, total protein (5 mg).
B) Quantification of three experiments performed identically to the
representative experiment shown in (A). Bars represent mean 6 SEM of
the amount of ubiquitinated transporter relative to total GlyT2
expression. *, significant difference with respect to control, p,0.05, **
p,0.01 (ANOVA with Tukey’s post-hoc test). C) Primary neurons were
treated identically as in (A) for 2 h at 37uC. The cells were then
harvested, lysed and whole cell lysates (40 mg/lane) were resolved by
SDS-PAGE and analyzed by immunoblotting with anti-Ubiquitin
antibody (clone P4D1). As a loading control, blots were reprobed with
anti-tubulin.
doi:10.1371/journal.pone.0058863.g007
Ubiquitination in GlyT2 Endocytosis and Turnover
PLOS ONE | www.plosone.org 8 March 2013 | Volume 8 | Issue 3 | e58863
intracellular trafficking of proteins. Monensin does not prevent
endocytosis but rather, by blocking protein recycling to the plasma
membrane and likely degradation, it promotes the accumulation
of endocytosed membrane proteins [23,32–34].
We first examined the effect of PYR41, a cell-permeable specific
inhibitor of the E1 ubiquitin-activating enzyme that catalyzes an
initial and critical step in the protein ubiquitination pathway [35].
As expected, monensin promoted the intracellular accumulation of
GlyT2 (Fig. 1A, B) with a concomitant marked decrease in protein
levels in the plasma membrane (Fig. 1B, E). When cells were
pretreated with PYR-41 (50 mM) and then incubated with
monensin (35 mM), a considerable reduction of GlyT2 endocytosis
with a substantial amount of the transporter remaining at the cell
surface was observed (Fig. 1D, E). Immunoprecipitation experi-
ments provided direct evidence that inhibition of GlyT2
ubiquitination underlies the reduction in GlyT2 endocytosis
(Fig. 1F, G). MDCK cells expressing wild-type GlyT2 were
maintained in the presence or absence of PYR41 and the
ubiquitinated transporter was immunoprecipitated from cell
lysates with agarose-conjugated anti-multiubiquitin (clone FK2),
an antibody that recognizes poly- and mono-ubiquitinated
proteins [36], and samples were then analyzed by Western blot
with anti-GlyT2 antibodies. Indeed, the inhibition of E1 ubiquitin-
activating enzyme by PYR41 clearly reduced the amount of
ubiquitinated GlyT2 (56.9766.30% SEM, Fig. 1G), indicating a
positive correlation between ubiquitination and constitutive GlyT2
internalization.
Lysine clusters in different cytosolic domains have been
identified as ubiquitination sites required for endocytosis of
GLT1 [20] and DAT [17] neurotransporters. To investigate this
phenomenon in GlyT2, we first examined the contribution of each
residue (K751, K773, K787 and K791) present in the C-terminus
of GlyT2 to its constitutive endocytosis by immunofluorescence
confocal microscopy and biotinylation assays. These GlyT2 lysine
residues are evolutionarily conserved in most animal species (as
evident in sequence alignments: Fig. 2A, in red), suggesting an
important role in GlyT2 function. Mutants in which each of the
four lysine residues was substituted individually to arginine
displayed similar constitutive internalization to that observed for
the wild-type protein when assessed by confocal microscopy
(Fig. 2B). Likewise, quantitative biotinylation revealed similar
levels of remaining transporter at the cell surface in the presence of
monensin for each mutant and the wild-type transporter (Fig. 2C,
D), suggesting that ubiquitination of the individual K751, K773,
K787 and K791 residues contributed weakly to GlyT2 constitutive
endocytosis. [3H]-glycine uptake assays depicted in fig. 2E showed
similar transport activity levels for every mutant and wild-type
GlyT2. Next, we generated a GlyT2 mutant in which all four C-
terminal lysines are simultaneously substituted by arginines (4KR
mutant) and the constitutive endocytosis was assayed as above. As
immunofluorescence pictures show, in contrast to wild-type
Figure 8. UCHL1 inhibition impairs Glyt2 constitutive endocytosis in neurons. A) Representative immunoblot of brainstem and spinal cord
primary neurons. Cells were pretreated for 2 h with vehicle (DMSO) or LDN-57444 (UCHL1 inhibitor: 10 mM) and were then exposed to monensin
(35 mM, 30 min) or the vehicle alone (EtOH), in the presence or absence of UCHL1. Cell surface proteins were labeled with sulfo-NHS-SS-biotin and the
biotinylated proteins were pulled down with streptavidin-agarose beads. GlyT2 expression was analyzed in Western blots using calnexin
immunodetection as a control of intracellular non-biotinylated protein. B, biotinylated protein (30 mg); T, total protein (10 mg). B) Densitometric
analysis of four independent Western blots as in (A) relative to the control values (Veh). Data represent the means 6 SEM. **, significant difference
with respect to control; p,0.01 (ANOVA with Tukey’s post-hoc test). C) Primary neurons were incubated with vehicle or LDN-57444 as described
above, the cells were lysed and the ubiquitinated GlyT2 was immunoprecipitated with agarose-conjugated anti-multiubiquitin antibody. The
immunoprecipitates were probed with anti-GlyT2 antibody. Ub, anti-multiubiquitin immunoprecipitation (75 mg); T, total protein (10 mg). D)
Quantification of four experiments performed as described in (C). Bars represent the mean 6 SEM level of LDN-57444-treated ubiquitinated
transporter relative to that of ubiquitinated transporter in vehicle-treated cells. *, significant difference with respect to control; p,0.05 (Student’s t-
test).
doi:10.1371/journal.pone.0058863.g008
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GlyT2, the 4KR mutant predominantly remained at the cell
surface in the presence of monensin, suggesting a role for the C-
terminal lysine cluster in the constitutive internalization of the
transporter (Fig. 3A–D). These findings were further supported by
quantification of transporter levels at the cell surface by
biotinylation (Fig. 3E, F). In addition, immunoprecipitation
experiments provided direct evidence that lysine cluster ubiquiti-
nation is a critical requirement for the constitutive endocytosis of
GlyT2 (Fig. 3G, H). Fig. 3G and H shows that 4KR mutant was
around 32% less ubiquitinated than the wild-type transporter but
it still remained ubiquitinated. Redundancy in ubiquitination sites
has been frequently reported [33], such that other lysines are
ubiquitinated in the absence of the main conjugation sites. This
may account for the residual ubiquitination of the 4KR mutant.
Alternatively, other intracellular lysine residues may be ubiquiti-
nated, but in either case its contribution to the constitutive
endocytosis does not appear to be functionally relevant. [3H]-
glycine uptake assays showed similar transport activity for 4KR
mutant and wild-type GlyT2 (Fig. 3I). Together, these results point
to C-terminal K751, K773, K787 and K791 of GlyT2 as targets of
the ubiquitination required for its constitutive endocytosis.
Neuronal localization of GlyT2 is not impaired by
substitution of the C-terminal lysine cluster
Regarding the synaptic localization of the transporter, C-
terminus region of GlyT2 has been suggested to be important for
synaptic localization of the transporter since modification of its C-
terminal type III PDZ domain binding motif reduces co-
localization of GlyT2 with different synaptic markers [37]. To
test if the C-terminal lysine cluster was also implicated in the
neuronal localization of transporter we transfected primary
hippocampal neurons with GlyT2 wild-type and 4KR mutant
constructs and measured co-localization with syntenin-1, a PDZ
domain protein, and syntaxin1A, a Soluble NSF Attachment
Protein REceptor (SNARE) complex component (Fig. 4) We have
selected syntenin-1 and syntaxin1A because they are the only
proteins whose interaction with GlyT2 has been described in
nervous tissue preparations [38,13]. In agreement with previous
results [37] no GlyT2 immunostaining was detected in non-
transfected neurons (data not shown), indicating that the
fluorescence was derived from the exogenous constructs of GlyT2.
As figure 4 shows, both GlyT2 and 4KR present similar punctate
distribution pattern (Fig. 4A–B) and similar levels of co-localization
with syntaxin1A and sintenin-1 (Fig. 4C), indicating that the C-
terminal lysine cluster appears not to be implicated in the synaptic
localization of GlyT2. Together these results suggest that
simultaneous substitution of C-terminal K751, K773, K787 and
K791 residues does not affect GlyT2 interactions with syntaxin1A
and syntenin-1, and therefore neither the proper neuronal
localization of GlyT2.
Ubiquitination modulates the intracellular distribution
and degradation of GlyT2
To further investigate whether deficient ubiquitination alters the
intracellular localization of GlyT2 we co-expressed wild-type or
4KR GlyT2 with different Rab proteins fused to green fluorescent
protein in MDCK cells. Small Rab GTPases are well-known
organizers of intracellular trafficking of membrane proteins in
eukaryotic cells and they serve as markers of distinct endosomal
compartments [39]. We previously showed that at steady state,
most intracellular GlyT2 resides in a subset of Rab11-positive
recycling endosomes in nerve terminals and neurons [16].
Accordingly, double immunofluorescence images revealed that at
the steady state also in MDCK cells, intracellular GlyT2 mainly
co-localized with Green Fluorescent Protein (EGFP)-Rab11, a
marker of slow recycling endosomes. By contrast, we observed a
small co-localization with EGFP-Rab7, a marker of late
endosomes (Fig. 5A, C, I). The 4KR mutant accumulated on
the cell surface and no intracellular vesicles expressing this
transporter were detected (Fig. 5E, G). Moreover, the abundant
EGFP-Rab11 and GlyT2-positive vesicles observed after 30 min
of monensin treatment, suggest that GlyT2 is constitutively mainly
sorted to the slow recycling pathway (Fig. 5D, I). In accordance
with the reduced endocytosis of the 4KR mutant, only a few
vesicles were observed containing both the 4KR transporter and
EGFP-Rab11 (Fig. 5H, I).
In recent years, the importance of ubiquitination in controlling
endocytosis and degradation of plasma membrane proteins has
been established. Thus, we investigated whether ubiquitination
affects the stability of GlyT2. We compared the degradation rate
of wild-type GlyT2 and the ubiquitin-deficient 4KR mutant in
untreated and PMA-treated cells in the presence of cycloheximide,
a blocker of protein synthesis (Fig. 6). As we recently reported that
PKC-dependent GlyT2 endocytosis is mediated by increased
GlyT2 ubiquitination [23], PMA was used to establish the
opposite scenario to that seen in the ubiquitin-deficient 4KR
mutant. Quantification of Western blots revealed that the wild
type protein decreased rapidly after 2 hours, with only
54.4469.72% of initial protein remaining after 6 h. By contrast,
the 4KR mutant protein was more stable and persisted longer in
these cells. Exposure to Phorbol 12-Myristate 13-Acetate (PMA)
markedly accelerated the degradation of GlyT2 and after 6 h,
protein levels had fallen by 73.5666.39% of initial amount
(Fig. 6A, B). Increased degradation by PMA has been previously
observed for DAT which is completely degraded within 2 h of
PKC activation [40]. In accordance with the absence of the major
target of PKC-induced ubiquitination (lysine 791, [23]), the 4KR
mutant was stable through 2 h of PMA treatment. After longer
PMA exposure time a small degradation was observed (Fig. 6A, B),
probably as result of ubiquitination of other intracellular lysine
residues when K791 is absent, as indicated above (see comments to
Fig. 3G, H). Indeed, immunofluorescence assays showed a
significant increase in GlyT2 and EGFP-Rab7 colocalization after
PMA treatment (Fig. 6F, G) further supporting that acceleration of
GlyT2 endocytosis by PKC-mediated ubiquitination directs the
transporter mainly to degradation pathway.
In conclusion, our data demonstrate that in MDCK cells GlyT2
primarily resides at steady state and after constitutive endocytosis
in slow recycling pathway endosomes. Ubiquitination modulates
the GlyT2 turnover, in such that enhanced ubiquitination
increases the transporter degradation shortening its half-life, while
decreased ubiquitination promotes its stability.
The ubiquitination status of GlyT2 in neurons is highly
responsive to the free ubiquitin pool
The intracellular location of GlyT2 in recycling endosomes
implies that a mechanism of deubiquitination exists that permits
GlyT2 to return to the cell surface. Like many other post-
translational modifications, ubiquitination is reversible and
deubiquitination is accomplished by deubiquitinating enzymes
(DUBs). DUBs are fundamental in the regulation of protein
ubiquitination, they influence in crucial functions in the nervous
system and its dysfunction is involved in some neurodegenerative
diseases [26,27,41]. The availability of ubiquitin to target proteins
towards different cellular pathways is essential to maintain the
homeostasis and activity of the nervous system. Indeed, ubiquitin
carboxyl-terminal hydrolases, UCHL1 and UCHL3, are abun-
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dantly expressed in the CNS, where they play important roles in
the generation and modulation of free monomeric ubiquitin
[26,27,41,42]. Given the specific expression of GlyT2 in neurons,
we used primary cultures of brainstem neurons to study the effect
of inhibiting UCHL1 and UCHL3 on the ubiquitination and
constitutive endocytosis of endogenous GlyT2.
Specific inhibition of UCHL1 with LDN-57444 and of UCHL3
with TCID diminished GlyT2 ubiquitination, which was more
pronounced when UCHL1 was inhibited and when cells were
exposed to these inhibitors for longer periods (Fig. 7A, B). The
relevant control exerted by these DUBs on ubiquitin homeostasis
may account for these effects since pharmacological blocking of
UCHL1 or UCHL3 reduced the monomeric ubiquitin pool, in
turn restricting the ubiquitination of GlyT2 in neurons (Fig. 7C).
When we investigated the effect of UCH-L1 inhibition on the
constitutive endocytosis of GlyT2, the decrease in biotinylated
GlyT2 induced by monensin was notably attenuated after
exposure to the UCHL1 inhibitor for 2 h (Fig. 8A, B), an effect
that was paralleled by a significant reduction in ubiquitination of
the transporter (Fig. 8C, D). Together, these data indicate a strict
dependence of constitutive endocytosis on ubiquitination of GlyT2
in neurons, supporting our findings in MDCK cells. Furthermore,
these results suggest that although GlyT2 seems not to be directly
deubiquitinated by UCHL1 and UCHL3, both DUBs indirectly
modulate the dynamics of GlyT2 ubiquitination/deubiquitination,
by controlling monomeric ubiquitin homeostasis in neurons.
Discussion
We previously demonstrated that GlyT2 is recycled between the
cell surface and cell interior via constitutive and PKC-regulated
clathrin-dependent endocytosis, resulting in the localization of a
large proportion of the transporter in a subset of Rab11-positive
endosomes in CNS nerve terminals under steady-state conditions
[14,16]. The C-terminal tail of other SLC6 family members is
known to play a critical role in transporter trafficking, stability and
degradation [19,20,22,25,43] and, in agreement with that, we
have described an increase in the ubiquitination of GlyT2 in lysine
791 in the C-terminal tail as the major determinant of PKC-
induced GlyT2 endocytosis [23]. Ubiquitination of neuronal
membrane proteins controls their internalization and endocytic
sorting to recycling and/or degradation pathways, and is thus an
important mechanism for neuronal development and function
[44]. Whereas ubiquitination is proposed as the mechanism for
PKC-dependent endocytosis of several neurotransmitter trans-
porters [17,19,20] its role in constitutive endocytosis appears to be
specific for each transporter [19,24,25].
In the present study, we sought to elucidate the putative role of
ubiquitination in the constitutive internalization and sorting to
recycling and/or degradation pathways of neuronal GlyT2. Our
results demonstrate that constitutive GlyT2 endocytosis is depen-
dent on ubiquitination, as indicated by the decreased ubiquitina-
tion and concomitant accumulation of GlyT2 at the cell surface
following inhibition of E1 ubiquitin-activating enzyme. This
enzyme is the first component of the multi-step enzymatic process
(E1s, E2s and E3s) that mediates the transfer of ubiquitin to lysine
residues on target proteins. Indeed, substituting the C-terminal
cluster of lysine residues significantly inhibited GlyT2 internaliza-
tion, pointing to the K751, K773, K787 and K791 residues as
major targets of ubiquitination in constitutive GlyT2 endocytosis.
Similarly, ubiquitination of cytosolic lysine clusters has been
implicated in the constitutive endocytosis of the glutamate
neurotransporter (GLT1) [25]. The partial decrease of 4KR
mutant ubiquitination suggests a basal level of ubiquitination of
GlyT2, or alternatively, redundant ubiquitination of other lysines
when the main conjugation sites are removed [33]. In this regard,
GlyT2 sequence contains additional potential sites for ubiquitina-
tion such as six lysine residues of its long intracellular N-terminal
domain, unique structural characteristic that distinguishes GlyT2
of other members of the neurotransmitter:sodium symporter
family (SLC6 gene family). Further site-mutagenesis studies will
be necessary to discern between these possibilities.
Moreover, the mutation of the C-terminal lysine cluster does
not alter the neuronal localization of GlyT2 as indicated by the
similar co-localization levels between 4KR mutant and GlyT2
wild type with the PDZ protein syntenin-1 and the SNARE
protein component syntaxin1A in hippocampal neurons. Both
proteins interact with GlyT2 and have been involved in the
regulation of its presynaptic localization and trafficking [37,38,13].
In addition to promoting internalization, ubiquitination of
neuronal membrane proteins can also dynamically control the
post-endocytic sorting to the recycling or lysosomal degradation
pathways [44]. Members of the small GTPase Rab family are
known organizers of intracellular membrane protein trafficking in
eukaryotic cells [39]. Our immunofluorescence studies reveal that
most GlyT2 is targeted to the recycling pathway after constitutive
endocytosis, reflected in the high level of co-localization of GlyT2
and Rab11, a protein that modulates slow recycling of proteins to
the plasma membrane via the pericentriolar recycling compart-
ment (or ‘long loop’: [45]). The low co-localization of GlyT2 with
the late endosomal marker Rab7 after 30 min of endocytosis
indicates that a small proportion of GlyT2 is targeted to the
lysosomal degradation pathway. These data support our previous
findings regarding the steady state localization of GlyT2 in
nervous tissue [16], and demonstrate that GlyT2 undergoes
continuous and efficient turnover between the plasma membrane
and the intracellular compartment. The requirement of ubiquiti-
nation for constitutive GlyT2 endocytosis and the subsequent
sorting demonstrated here contrasts with the pattern described for
the related dopamine transporter DAT. Constitutive DAT
endocytosis has been previously studied [43] and recent data
have demonstrated that DAT sorting to degradation and recycling
pathways occurs independently of N-terminal lysine ubiquitination
[24], suggesting distinct outcomes following the ubiquitination of
different membrane proteins. In addition, the analyses of the
degradation rate indicated that ubiquitination negatively modu-
lates GlyT2 turnover, as witnessed by the correlation between
ubiquitination status and GlyT2 stability. Increased PKC-mediat-
ed ubiquitination therefore directs GlyT2 mainly to the degrada-
tion pathway leading to an efficient downregulation of the protein,
whereas reduced C-terminal lysine ubiquitination increases its
stability.
The availability of ubiquitin to target proteins in distinct cellular
pathways is essential for nervous system function and DUBs
contribute to ubiquitin homeostasis by recycling ubiquitin from
lysosomal and proteasomal substrates. The human genome
encodes nearly 95 DUBs [46], although their specific substrates
and physiological roles are still poorly understood [27]. Presyn-
aptic ubiquitin pools are particularly sensitive to variations in
ubiquitin availability to be away from the site of synthesis [47].
UCHL1 is abundantly expressed in neurons and is one of the main
mediators of ubiquitin homeostasis, accounting for 60% of
hippocampal deubiquitination [26,48]. The significant reduction
in neuronal monomeric ubiquitin levels following pharmacological
blockade of UCHL1 and UCHL3 observed in our assays and also
described by other authors [26] may account for the significant
decrease in GlyT2 ubiquitination described here. However, we
cannot rule out the possibility that ubiquitin depletion by UCHL1
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inhibition results in the up-regulation of DUBs acting on GlyT2.
Compensatory mechanisms have been described in every UCH-
L1 and Usp14-deficient mice where the lowered ubiquitin pool by
the suppression of either DUB induced an increase in mRNA and
protein levels of each other [49]. However, the rapid reduction in
GlyT2 ubiquitination observed only 1 hour after of pharmaco-
logical UCHL1 blockade is not consistent with this genetic
mechanism. Thus, our findings suggest that constitutive internal-
ization of GlyT2 in neurons depends on ubiquitination, and that
its ubiquitination status is highly sensitive to ubiquitin homeostasis.
It should be noted that ubiquitination is an important regulatory
mechanism for inhibitory synaptic neurotransmission through
control of the trafficking and turnover of glycine and GABA
receptors [50–52]. In this regard, the modulation of GlyT2
turnover by ubiquitination described here (through endocytosis,
recycling and degradation) contributes to our understanding of
how inhibitory neurotransmission is regulated. As GlyT2 supplies
glycine to refill synaptic vesicles in inhibitory nerve terminals, the
regulation of dynamic and active GlyT2 cellular trafficking is
critical for inhibitory glycinergic neurotransmission. This is
evident through the disruption in transporter membrane traffick-
ing associated with certain GlyT2 gene (SLC6A5) mutations
associated with hyperekplexia [5,9]. Modulation of the recruitable
GlyT2 internal pool facilitates rapid and efficient neuronal
adaptation to changes in synaptic neurotransmitter concentra-
tions. Thus, GlyT2 modulation through ubiquitination increases
our knowledge in the processes that control glycinergic inhibitory
neurotransmission. A better understanding of the molecular
mechanisms that underlie functional processes is a requirement
for a more specific and precise future clinical intervention
strategies in glycinergic neuromotor disorders including hyper-
ekplexia and myoclonus, or other dysfunctions as neuropathic pain
or epilepsy.
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